Skip to Main content Skip to Navigation
Journal articles

The glycoprotein GP130 governs the surface presentation of the G protein–coupled receptor APLNR

Abstract : Glioblastoma is one of the most lethal forms of adult cancer, with a median survival of ∼15 mo. Targeting glioblastoma stem-like cells (GSCs) at the origin of tumor formation and relapse may prove beneficial. In situ, GSCs are nested within the vascular bed in tight interaction with brain endothelial cells, which positively control their expansion. Because GSCs are notably addicted to apelin (APLN), sourced from the surrounding endothelial stroma, the APLN/APLNR nexus has emerged as a druggable network. However, how this signaling axis operates in gliomagenesis remains underestimated. Here, we find that the glycoprotein GP130 interacts with APLNR at the plasma membrane of GSCs and arbitrates its availability at the surface via ELMOD1, which may further impact on ARF-mediated endovesicular trafficking. From a functional standpoint, interfering with GP130 thwarts APLNR-mediated self-renewal of GSCs ex vivo. Thus, GP130 emerges as an unexpected cicerone to the G protein–coupled APLN receptor, opening new therapeutic perspectives toward the targeting of cancer stem cells.
Document type :
Journal articles
Complete list of metadata
Contributor : Julie Gavard Connect in order to contact the contributor
Submitted on : Friday, September 10, 2021 - 8:18:52 AM
Last modification on : Wednesday, April 27, 2022 - 3:53:53 AM
Long-term archiving on: : Saturday, December 11, 2021 - 6:09:58 PM


Publication funded by an institution



Kilian Trillet, Kathryn Jacobs, Gwennan André-Grégoire, An Thys, Clément Maghe, et al.. The glycoprotein GP130 governs the surface presentation of the G protein–coupled receptor APLNR. Journal of Cell Biology, Rockefeller University Press, 2021, 220 (9), pp.e202004114. ⟨10.1083/jcb.202004114⟩. ⟨inserm-03340113⟩



Record views


Files downloads